Sarah Keene
Family · Louisville, KYNPI 1336697796
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. TG Therapeutics, Inc. accounts for 63.4% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $15,036, more than ten times the $108 reported in 2021. Among family clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $183.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TG Therapeutics, Inc.$11K
- Genentech USA, Inc.$4K
- AstraZeneca$439
- Genentech, Inc.$355
- E.r. Squibb & Sons, L.L.C.$283
- AbbVie$268
- plus $548 from 13 others
What the payments were for
- Consulting fees$3,80022%
- Speaking & faculty fees$7,61344%
- Travel & lodging$2,69316%
- Food & beverage$2,76816%
- Education$3502%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TG Therapeutics, Inc. | 28 | $10,919 |
| Genentech USA, Inc. | 13 | $4,411 |
| AstraZeneca(2 entities) | 8 | $439 |
| Genentech, Inc. | 3 | $355 |
| E.r. Squibb & Sons, L.L.C. | 3 | $283 |
| AbbVie | 14 | $268 |
| Novartis | 6 | $112 |
| Acadia Pharmaceuticals Inc | 1 | $109 |
| Johnson & Johnson | 4 | $70 |
| Bristol Myers Squibb | 3 | $51 |
| Amgen | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Sobi, Inc | 1 | $22 |
| EMD Serono, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Sandoz | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Smith+Nephew | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,224 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VumerityDiroximel Fumarate | 22 | $190,373 |
| Kesimpta PenOfatumumab | 21 | $173,309 |
| Teriflunomide | 54 | $55,920 |
| Dalfampridine ErDalfampridine | 58 | $30,999 |
| Glatiramer Acetate | 12 | $21,618 |
| NuedextaDextromethorphan Hbr/Quinidine | 11 | $16,590 |
| Lacosamide | 12 | $3,181 |
| Dimethyl Fumarate | 15 | $2,608 |
| Levetiracetam | 40 | $2,590 |
| Gabapentin | 161 | $2,458 |
| Baclofen | 126 | $2,004 |
| Carbamazepine | 19 | $754 |
| Pregabalin | 13 | $670 |
| ValacyclovirValacyclovir Hcl | 11 | $387 |
| Duloxetine Hcl | 37 | $311 |
Paid to pharmacies, not to this prescriber.
Other family in Louisville
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Shelley WaldmanLouisville$59K
- Esther MuhsLouisville$44K
- Barbra CaveLouisville$41K
- Kayla WilsonLouisville$40K
- Christin ThompsonLouisville$38K
- Wendi HallerLouisville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.